Clinical efficacy and toxicity of gefitinib in patients with lung cancer

Lancet. 2003 Jun 7;361(9373):1992-3. doi: 10.1016/S0140-6736(03)13573-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Gefitinib
  • Humans
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Neoplasms / complications
  • Lung Neoplasms / drug therapy*
  • Pulmonary Fibrosis / diagnostic imaging
  • Pulmonary Fibrosis / etiology*
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use
  • Radiography

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Gefitinib